.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
IHH Healthcare has recently identified India as a high-priority growth market. Consequently, the group aims to accelerate the Fortis Healthcare expansion to become a top private healthcare player. Group CEO Prem Kumar Nair announced plans to increase IHH’s stake in Fortis to 50% over the medium term. This strategic move follows the resolution of the mandatory tender offer. Moreover, the group believes this investment will strengthen its clinical footprint across Asia.
The group plans to increase its bed capacity to 10,000 in India by 2030. Furthermore, IHH has committed a capital expenditure of ₹2,500 crore for the next three years. This investment will primarily fund brownfield projects at existing facilities. For instance, expansion will target clusters in Punjab, Jalandhar, and Bengaluru. Additionally, the group will fully integrate Gleneagles into the Fortis network. Currently, the network spans 36 hospitals across the country.
Nair emphasized that growth must not compromise clinical quality. He believes that high-intensive-care beds are more valuable than a high volume of low-quality beds. Currently, Fortis operates with strong profitability levels. The group reports EBITDA margins between 23% and 24%. Therefore, the increased investment is expected to be earnings-per-share accretive. Meanwhile, IHH is also repositioning its diagnostics arm, Agilus, to focus on high-end genomics.
Q1: What is the target stake for IHH in Fortis?
IHH Healthcare aims to increase its shareholding in Fortis Healthcare to 50% over the medium term to drive long-term value.
Q2: How many beds does IHH plan to have in India?
The group targets a total of 10,000 beds in India by 2030 through strategic brownfield expansion and full network integration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
IHH Healthcare plans to hike its stake in Fortis to 50% and expand capacity to 10,000 beds by 2030, reinforcing its focus on high-quality Indian healthcare....
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
